Clover Health Investments Corp CLOV shares are trading higher in Monday's after-hours session after the company reported better-than-expected top-line results and reaffirmed guidance.
Clover Health reported first-quarter revenue of $874.4 million, which beat the $787.34-million estimate. The company reported an adjusted net loss of $75.3 million.
Lives under management reached approximately 257,000 during the quarter, up from about 66,000 year-over-year.
"We are cautiously optimistic about the remainder of 2022, and are maintaining our expectations for a meaningful improvement over last year," said Mark Herbers, interim CFO of Clover Health.
Clover Health reaffirmed expectations for full-year 2022 revenue of $3 billion to $3.4 billion versus the $3.24-billion estimate.
See Also: Why Novavax Shares Are Falling After Hours
CLOV 52-Week Range: $1.95-$28.85.
According to data from Benzinga Pro, the stock was up 16.6% in after hours trading.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
